Buy, Sell, Hold: CoreWeave Near $100 Sparks Debate
CoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
Compare 2024 dividend aristocrats ETF fees to find the lowest cost option. This guide highlights expense ratios and what to look for in a low-cost fund.
27,654 articlesCoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
SpaceX is set to debut on the public market tomorrow after planning a record-breaking raise, drawing unprecedented in...
Ben Chester navigated a path from crushing debt renting to a thriving landlord with eight properties, three short-ter...
Crypto PACs are financing GOP primaries at a rapid pace even as the Senate stalls on major crypto legislation, alteri...
The FDA approved bemotrizinol for over-the-counter sunscreen use on June 9, 2026, introducing the first new ingredien...
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
San Francisco-based Framework Ventures closes its fourth fund at $400 million, expanding beyond crypto into frontier ...
Palantir stock today climbed as the company announced a strategic AI collaboration. This article breaks down the driv...
Jim Cramer raised questions about the credibility of June payroll data amid a surge in private capital spending by te...
A Chinese regulator warned of a security backdoor in Anthropic's Claude Code, signaling tightened AI-tool oversight a...
As tax rules permanently allow full deductions for qualifying property in the year of service, corporate buyers are e...
Microsoft is riding a fast-growing AI wave, but its stock hasn’t followed the surge. Here’s how analysts and models v...